P/E Ratio
Higher than 48% of Healthcare sector peers
Updated 167h ago
Sector Performance
48th percentileTMO
24.6x
Sector Median
24.6x
Sector Avg
28.9x
Deep Analysis
Thermo Fisher Scientific Inc. (TMO) has a P/E Ratio of 24.6x as of June 2026.
This places TMO in the 48th percentile of the Healthcare sector, which has a median P/E Ratio of 24.6x and a sector average of 28.9x. TMO's P/E Ratio is 0.1% below the sector median. In context: Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Frequently Asked Questions
What does the P/E Ratio tell investors about TMO?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
How does TMO's P/E Ratio compare to its sector?
TMO's P/E Ratio of 24.6x compares to a Healthcare sector median of 24.6x, placing it in the 48th percentile.
Who are TMO's closest peers by P/E Ratio?
The closest Healthcare peers by P/E Ratio include: AMGN (24.7x), BSX (25.8x), A (23.0x), AZN (27.0x), VEEV (27.1x).
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master TMO's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full TMO research report →TMO
24.6x
Sector Median
24.6x
Sector Avg
28.9x
How TMO's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.